Support Peer's Cykelnerven ride for MS

The Progressive MS Alliance 2024 Progress Report

Professor Klaus Schmierer on Cladribine use in MS

MSIF's webpage and resources on access to MS Healthcare

Key steps to get started in using the WHO EML in your advocacy efforts

WHO EML associated case study from the MS movement - Malaysia

The impact of WHO EML listing on access to MS DMTs

WHO EML associated case study from the MS movement - New Zealand

A video message from Peer Baneke announcing the WHO's decision

Sharifah's story - Malaysia

Tarrbinder's story - Malaysia

Abdelhakim's story - Morocco

Oumaima's story - Morocco

Dr Shanthi Viswanathan - Malaysia

Professor Belahsen - Morocco

National access to DMTs in India

Access to DMTs in Serbia

Access to DMTs in Thailand

National Essential Medicine List in Malaysia

Cykelnerven 2023 - Day Four

Cykelnerven 2023 - Day Three

Cykelnerven 2023 - Day Two

Cykelnerven 2023 - Day One

Cykelnerven - Chris Ramsey Interview

Cykelnerven - Route Trailer #2

Cykelnerven - Thomas Riedel Interview

Cykelnerven - Tomas' Story

Progressive MS Alliance Announces New Global Research Initiative on Well-Being #shorts

MSIF application to the World Health Organization Essential Medicine List - Nick Rijke

Developing treatments to end MS progression: Recent advances and promising research